Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of California, San Francisco